Monitoring Tumor Response to Linifanib Therapy with SPECT/CT Using the Integrin αvβ3–Targeted Radiotracer 99mTc-3P-RGD2 99mTc-3P-RGD2: An Integrin αvβ3–Targeted Radiotracer to Monitor Linifanib TherapyShundong Ji, Sarah R. Mudd, Daniel H. Albert et al.|Journal of Pharmacology and Experimental Therapeutics|2013Cited by 26
Pharmacodynamic Evaluation of Irinotecan Therapy by FDG and FLT PET/CT Imaging in a Colorectal Cancer Xenograft ModelSarah R. Mudd, Yanping Luo, Kimberley D. Holich et al.|Molecular Imaging and Biology|2011Cited by 19
FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft modelSarah R. Mudd, Mark L. Day, Yanping Luo et al.|Cancer Chemotherapy and Pharmacology|2012Cited by 5